Sykes, B.W., Hallowell, G.D. Aims: To compare the efficacy of 2 doses of omeprazole, and to report the healing rate of glandular EGUS with omeprazole. Methods: Thoroughbred racehorses in training with grade II/IV or greater glandular EGUS were identified on gastroscopy. Horses were randomised to either 2.0 g (high dose) or 0.8 g (low dose) omeprazole per os s.i.d., equivalent to 4.0 and 1.6 mg/kg bwt per os s.i.d., respectively for a 500 kg horse. Repeat gastroscopy was performed at 33 plusminus 7 days. Results: Twenty-four affected horses were randomised equally. No differences between the groups were present. One horse in the low dose group was lost to follow-up for unrelated reasons. All horses, except one in the high dose group, had grade II/IV or greater squamous ulceration at Day 0. Ulcer healing (defined as a return to grade 0 - I/IV) occurred in 67% and 44% of the squamous, and 50% and 11% of the glandular ulcers in the high and low dose groups, respectively. A dose effect and P = 0.13 for improvement, for high and low dose respectively). Conclusions: Healing of EGUS is commonly incomplete at 33 days. A dose dependent response exists in the healing of squamous ulceration. Healing of glandular ulceration is inferior to healing of squamous ulceration. Practical significance: A reduction in the dose of omeprazole prior to control gastroscopy is likely to result in inadequate healing, even when 28 days of therapy is completed. Investigation of complimentary and/or alternative therapies for glandular EGUS is warranted.
BEVA is committed to serve and lead the equine veterinary profession in the championing of high standards of equine health and welfare and the promotion of scientific excellence and education throughout the world.